诺诚健华(09969)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09969 诺诚健华

休市中 12-05 16:09:08

14.360

-0.080

-0.55%

最高14.540	最低14.110	成交量436.79万
今开14.490	昨收14.440	日振幅2.98%
总市值253.02亿	流通市值214.54亿	总股本17.62亿
成交额6,239万	换手率0.29%	流通股本14.94亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09969","market":"HK","secType":"STK","nameCN":"诺诚健华","latestPrice":14.36,"timestamp":1764922148009,"preClose":14.44,"halted":0,"volume":4367920,"delay":0,"floatShares":1494000000,"shares":1762000000,"eps":-0.2863513787036604,"marketStatus":"休市中","change":-0.08,"latestTime":"12-05 16:09:08","open":14.49,"high":14.54,"low":14.11,"amount":62393164,"amplitude":0.029778,"askPrice":14.36,"askSize":27000,"bidPrice":14.35,"bidSize":16000,"shortable":3,"etf":0,"ttmEps":-0.15693817715291075,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":7,"adr":0,"listingDate":1584892800000,"exchange":"SEHK","adjPreClose":14.44,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":0.8850824602493004,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688428","market":"SH","secType":"STK","nameCN":"诺诚健华","latestPrice":24.99,"timestamp":1764918000000,"preClose":24.84,"halted":0,"volume":2668300,"delay":0,"premium":"-47.83"}},"requestUrl":"/m/hq/s/09969","defaultTab":"news","newsList":[{"id":"2588880472","title":"诺诚健华（688428）披露证券变动月报表，12月04日股价上涨1.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588880472","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588880472?lang=zh_cn&edition=full","pubTime":"2025-12-04 22:20","pubTimestamp":1764858034,"startTime":"0","endTime":"0","summary":"截至2025年12月4日收盘，诺诚健华报收于24.84元，较前一交易日上涨1.89%，最新总市值为438.34亿元。公司近日发布公告，披露截至2025年11月30日的证券变动月报表。公告显示，诺诚健华医药有限公司法定股本无变动，已发行股份总数保持不变。公司存在股权激励计划，包括2023年及2024年人民币股股份激励计划，部分限制性股票已失效，但本月未发生新股发行或库存股转让。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400039635.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09969","161027","BK1161","688428","BK0239","BK1574"],"gpt_icon":0},{"id":"2589283664","title":"每日卖空追踪 | 诺诚健华 12月04日卖空量成交8.9万股，卖空比例为2.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589283664","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589283664?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:30","pubTimestamp":1764837042,"startTime":"0","endTime":"0","summary":"诺诚健华北京时间12月04日，涨3.14%，卖空量成交8.9万股，较上一交易日减少85.5%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163649a4cc3901&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163649a4cc3901&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09969","BK1161"],"gpt_icon":0},{"id":"2588074906","title":"医药股普遍回暖 荣昌生物(09995)涨4.26% 交银国际料明年内地医药板块稳中向好态势延续","url":"https://stock-news.laohu8.com/highlight/detail?id=2588074906","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588074906?lang=zh_cn&edition=full","pubTime":"2025-12-04 10:58","pubTimestamp":1764817092,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药股普遍回暖，荣昌生物 涨4.26%，康方生物涨3.89%，金斯瑞生物科技涨3.11%，康诺亚-B涨2.95%，科伦博泰生物-B涨2.45%，诺诚健华涨1.79%，药明生物涨1.63%，泰格医药涨1.38%，药明康德涨1.33% 。交银国际发表报告指，予内地医药行业领先评级。如该行此前预期，内地医药行业2025年迎来关键转折。2026年，该行认为板块稳中向好态势延续，但影响市场表现的核心因素或呈分化态势。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250110/NmI5OTlmYjAxY2FmOGFlNWZkYjg2NDM0MTE4MzUwMDcw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NmI5OTlmYjAxY2FmOGFlNWZkYjg2NDM0MTE4MzUwMDcw.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1970883","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU0856984785.SGD","LU2399975544.HKD","02359","LU0588546209.SGD","09969","LU2476274720.SGD","09926","LU0634319403.HKD","BK1587","BK0239","LU0823426308.USD","LU2488822045.USD","LU0359202008.SGD","LU1961090484.USD","688331","BK1589","LU0181495838.USD","BK1515","LU0326950275.SGD","LU0819121731.USD","IE00BPRC5H50.USD","LU0307460666.USD","LU1720050803.USD","LU0359201612.USD","LU0417516571.SGD","BK1141","01548","BK1574","09995","BK1610","LU0561508036.HKD","LU1688375341.USD","03329","LU0052750758.USD","06990","LU2242644610.SGD","LU0516423091.SGD","LU1880383366.USD","LU0516422952.EUR","02162","159938","02269","09939","HK0000320264.USD","LU2148510915.USD","03347","LU2039709279.SGD","LU1046422090.SGD","LU2328871848.SGD"],"gpt_icon":0},{"id":"2588606017","title":"每日卖空追踪 | 诺诚健华 12月03日卖空量成交25.5万股，卖空比例为4.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588606017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588606017?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:30","pubTimestamp":1764750637,"startTime":"0","endTime":"0","summary":"诺诚健华北京时间12月03日，跌1.41%，卖空量成交25.5万股，较上一交易日减少50.96%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203163649a4c9f152&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203163649a4c9f152&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","BK1574","BK1161"],"gpt_icon":0},{"id":"2588017629","title":"诺诚健华12月03日遭主力抛售218.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588017629","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588017629?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:15","pubTimestamp":1764749759,"startTime":"0","endTime":"0","summary":"12月03日, 诺诚健华股价跌1.41%，报收14.00元，成交金额8800.5万元，换手率0.42%，振幅3.66%，量比1.41。诺诚健华今日主力资金净流出218.8万元，连续3日净流出，上一交易日主力净流出52.5万元。该股近5个交易日下跌4.92%，主力资金累计净流出213.2万元；近20日主力资金累计净流入2703.8万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203162154a7210675&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203162154a7210675&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","BK1161","BK1574"],"gpt_icon":0},{"id":"2588376036","title":"诺诚健华12月02日遭主力抛售52.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588376036","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588376036?lang=zh_cn&edition=full","pubTime":"2025-12-02 16:15","pubTimestamp":1764663345,"startTime":"0","endTime":"0","summary":"12月02日, 诺诚健华股价跌2.41%，报收14.20元，成交金额8627.2万元，换手率0.41%，振幅3.51%，量比1.28。诺诚健华今日主力资金净流出52.5万元，上一交易日主力净流出340.1万元。该股近5个交易日下跌3.34%，主力资金累计净流入305.1万元；近20日主力资金累计净流入3399.7万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202162002a4c79675&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202162002a4c79675&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09969","BK1574"],"gpt_icon":0},{"id":"2588036396","title":"诺诚健华ICP-248片启动Ⅰ期临床 适应症为恶性血液肿瘤和髓系恶性肿瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=2588036396","media":"新浪财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588036396?lang=zh_cn&edition=full","pubTime":"2025-12-02 12:03","pubTimestamp":1764648180,"startTime":"0","endTime":"0","summary":"药物临床试验登记与信息公示平台数据显示，北京诺诚健华医药科技有限公司的一项评价ICP-248片剂生物等效性和食物影响的随机、开放、单剂量、四周期、四交叉的I期临床研究已启动。ICP-248片为化学药物，适应症为恶性血液肿瘤和髓系恶性肿瘤患者。恶性血液肿瘤是起源于造血系统的恶性疾病，髓系恶性肿瘤是造血干细胞的克隆性疾病，二者常表现为贫血、出血、感染等，诊断依赖血液和骨髓检查。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202125952978b1187&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202125952978b1187&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","BK1574","BK1161"],"gpt_icon":0},{"id":"2588155774","title":"每日卖空追踪 | 诺诚健华 12月01日卖空量成交21.4万股，卖空比例为5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588155774","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588155774?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:30","pubTimestamp":1764577840,"startTime":"0","endTime":"0","summary":"诺诚健华北京时间12月01日，跌1.82%，卖空量成交21.4万股，较上一交易日减少68.25%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116363195244a41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116363195244a41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","09969"],"gpt_icon":0},{"id":"2588774152","title":"诺诚健华12月01日主力净流出340.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2588774152","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588774152?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:15","pubTimestamp":1764576939,"startTime":"0","endTime":"0","summary":"12月01日, 诺诚健华股价跌1.82%，报收14.55元，成交金额6140.5万元，换手率0.28%，振幅2.43%，量比0.75。诺诚健华今日主力资金净流出340.1万元，上一交易日主力净流入396.2万元。该股近5个交易日上涨0.48%，主力资金累计净流入1270.9万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入3760.0万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116181695243f08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116181695243f08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","09969"],"gpt_icon":0},{"id":"2587751162","title":"诺诚健华宣布新型TYK2抑制剂Soficitinib治疗结节性痒疹的全球II期临床试验完成首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2587751162","media":"证券日报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587751162?lang=zh_cn&edition=full","pubTime":"2025-11-29 11:36","pubTimestamp":1764387398,"startTime":"0","endTime":"0","summary":"11月28日，诺诚健华医药有限公司（以下简称“诺诚健华”）宣布，公司自主研发的新型TYK2抑制剂Soficitinib（ICP-332）治疗结节性痒疹的全球II期临床试验完成首例患者给药。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511293578279828.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09969","BK1161","688428","BK0239","BK1574"],"gpt_icon":1},{"id":"2586189785","title":"诺诚健华：截至目前，公司暂无自研药品于欧盟范围内获批及销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2586189785","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586189785?lang=zh_cn&edition=full","pubTime":"2025-11-28 18:15","pubTimestamp":1764324916,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：请问贵公司近两年是否出口欧盟国家？诺诚健华（688428.SH）11月28日在投资者互动平台表示，尊敬的投资者，您好！截至目前，公司暂无自研药品于欧盟范围内获批及销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511283577874557.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511283577874557.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","688428","09969","BK0239","BK1161"],"gpt_icon":0},{"id":"2587226731","title":"每日卖空追踪 | 诺诚健华 11月28日卖空量成交15.8万股，卖空比例为4.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2587226731","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587226731?lang=zh_cn&edition=full","pubTime":"2025-11-28 16:30","pubTimestamp":1764318639,"startTime":"0","endTime":"0","summary":"诺诚健华北京时间11月28日，跌0.6%，卖空量成交15.8万股，较上一交易日减少77.75%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128164651a717218f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128164651a717218f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09969","BK1161"],"gpt_icon":0},{"id":"2586289514","title":"生物医药股悉数走强 荣昌生物(09995)涨6.65% 机构指医药行业近期震荡调整后估值已回落至相对低位","url":"https://stock-news.laohu8.com/highlight/detail?id=2586289514","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586289514?lang=zh_cn&edition=full","pubTime":"2025-11-26 10:08","pubTimestamp":1764122938,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药股悉数走强，截至发稿，荣昌生物 涨6.65%，复宏汉霖涨4.85%，君实生物涨4.43%，康诺亚-B涨4.01%，康方生物涨3.62%，泰格医药涨3.33%，诺诚健华涨3.14%。总体上，2026年预计政策端仍将驱动医药行业腾笼换鸟、创新升级。该机构看好2026年医药行业投资机会，近期震荡调整后估值已回落至相对低位，有望在2026年重启升势，投资思路上寻找医药硬科技和细分赛道α，推荐关注创新药、创新器械、医疗AI方向，关注医药消费复苏及独立第三方ICL。","market":"us","thumbnail":"https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1970350","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348783233.USD","LU0417516902.SGD","02162","399441","09995","LU0348767384.USD","LU0417516571.SGD","BK1576","LU0348766576.USD","LU1064130708.USD","BK0239","HK0000165453.HKD","LU2778985437.USD","161726","LU0561508036.HKD","BK1574","LU2476274720.SGD","IE00BPRC5H50.USD","LU2399975544.HKD","03347","688331","LU1720050803.USD","LU0417516738.SGD","LU2476274308.USD","09969","LU2328871848.SGD","IE00B543WZ88.USD","BK1141","LU0540923850.HKD","LU0348827113.USD","LU0348784397.USD","BK1161","LU2488822045.USD","LU0348735423.USD","LU1961090484.USD","IE00B5MMRT66.SGD","LU2148510915.USD","LU1794554557.SGD","01877","BK1515","02696","BK1587","LU1064131003.USD","LU1969619763.USD","LU0348825331.USD","09926","LU0634319403.HKD","BK1583"],"gpt_icon":0},{"id":"2586405574","title":"每日卖空追踪 | 诺诚健华 11月25日卖空量成交31.9万股，卖空比例为4.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586405574","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586405574?lang=zh_cn&edition=full","pubTime":"2025-11-25 16:30","pubTimestamp":1764059440,"startTime":"0","endTime":"0","summary":"诺诚健华北京时间11月25日，涨1.17%，卖空量成交31.9万股，较上一交易日减少54.23%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112516363995192f70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112516363995192f70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","09969"],"gpt_icon":0},{"id":"2586405576","title":"诺诚健华11月25日主力净流入913.2万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2586405576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586405576?lang=zh_cn&edition=full","pubTime":"2025-11-25 16:15","pubTimestamp":1764058508,"startTime":"0","endTime":"0","summary":"11月25日, 诺诚健华股价涨1.17%，报收14.65元，成交金额1.1亿元，换手率0.49%，振幅5.18%，量比1.25。诺诚健华今日主力资金净流入913.2万元，上一交易日主力净流出362.6万元。该股近5个交易日下跌0.07%，主力资金累计净流入618.7万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入3267.3万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125161521a4b8f109&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125161521a4b8f109&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09969","BK1161"],"gpt_icon":0},{"id":"2585103116","title":"每周股票复盘：诺诚健华（688428）奥布替尼2025年1-9月销售收入达10.10亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585103116","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585103116?lang=zh_cn&edition=full","pubTime":"2025-11-23 02:43","pubTimestamp":1763836991,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，诺诚健华报收于23.36元，较上周的25.34元下跌7.81%。本周，诺诚健华11月17日盘中最高价报25.42元。本周关注点来自业绩披露要点：奥布替尼2025年1-9月销售收入达10.10亿元，同比增长45.77%。来自机构调研要点：奥布替尼全球Ⅲ期试验将与Zenas分别于2025年底及2026年Q1启动。答：公司2025年1-9月总营业收入11.15亿元，同比增长59.85%，毛利率88.8%。公司已在2025年第四季度收到Zenas支付的现金首付款及500万股普通股，带来即期财务收益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300000627.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK0239","688428","09969","BK1161"],"gpt_icon":0},{"id":"2585193109","title":"生物医药股全线下跌 荣昌生物(09995)、金斯瑞生物科技(01548)跌超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585193109","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585193109?lang=zh_cn&edition=full","pubTime":"2025-11-21 11:36","pubTimestamp":1763696200,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药股全线下跌，荣昌生物(09995)跌6.42%，金斯瑞生物科技(01548)跌6.3%，复宏汉霖(02696)跌5.77%，康诺亚-B(02162)跌5.24%，药明生物(02269)跌5.16%，泰格医药(03347)跌4.91%，药明康德(02359)跌4.79%，科伦博泰生物-B(06990)跌4.55%，百济神州(06160)跌4.44%，诺诚健华(09969)跌4.44%，君实生物(01877)跌4.40%，再鼎医药(09688)跌4.17%，康方生物(09926)跌3.98%，药明合联(02268)跌3.76%。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250106/MzdhOTliMTI0NzhlMTgxMzU2MzczNzM1NA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/MzdhOTliMTI0NzhlMTgxMzU2MzczNzM1NA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1970077","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696","LU1064131003.USD","02162","09969","LU0140636845.USD","LU0348783233.USD","LU0456827905.SGD","LU0516422366.SGD","09688","SG9999014674.SGD","06990","01548","688331","LU0181495838.USD","LU0823426480.USD","LU1770034418.SGD","HK0000320264.USD","09926","LU0348766576.USD","161726","LU0516422440.USD","LU0456846285.SGD","LU0196878994.USD","LU0516423174.USD","LU2399975544.HKD","02269","LU0572944931.SGD","LU0348784397.USD","01877","HK0000165453.HKD","BK1521","BK1587","06160","LU2328871848.SGD","02268","LU0359201612.USD","LU2125910500.SGD","LU3063872942.SGD","IE00BPRC5H50.USD","LU0417516902.SGD","09995","LU0516422952.EUR","LU1242518931.SGD","03347","399441","LU0327786744.USD","BK1610","02359","BK1574"],"gpt_icon":0},{"id":"2584183688","title":"多年亏损、高管高薪、管线滞后 诺诚健华如何“止亏”？","url":"https://stock-news.laohu8.com/highlight/detail?id=2584183688","media":"理财周刊","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584183688?lang=zh_cn&edition=full","pubTime":"2025-11-19 17:38","pubTimestamp":1763545080,"startTime":"0","endTime":"0","summary":"2025年11月13日，诺诚健华医药有限公司交出了三季报，今年前三季度营收11.15亿元，同比增长59.85%；净亏损0.72亿元。该交易总金额超过20亿美元，Zenas将向诺诚健华支付1亿美元首付款和近期里程碑付款，以及700万股Zenas普通股股票。奥布替尼作为诺诚健华的首个商业化产品，自获批上市后，已成为公司绝对的收入支柱。截至目前，奥布替尼已在国内拿下四个血液瘤适应症。从三季报到全年盈亏平衡预期，诺诚健华看似即将迎来高光时刻。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119174603a7040b60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119174603a7040b60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","BK1161","BK1574"],"gpt_icon":0},{"id":"2584999067","title":"诺诚健华：前三季度净利润亏6441万","url":"https://stock-news.laohu8.com/highlight/detail?id=2584999067","media":"国际金融报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584999067?lang=zh_cn&edition=full","pubTime":"2025-11-19 14:33","pubTimestamp":1763534031,"startTime":"0","endTime":"0","summary":"11月13日，诺诚健华(688428.SH)发布2025年第三季度报告，前三季度实现营业收入11.15亿元，同比增长59.85%；归属于上市公司股东的净利润为亏损6441万元。营收增长主要得益于核心产品奥布替尼（宜诺凯?）销售收入持续增长以及与Prolium达成授权许可的首付款确认收入所致。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511193568693777.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511193568693777.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09969"],"gpt_icon":0},{"id":"2584295415","title":"10年积累终迎历史性拐点，是时候关注诺诚健华了","url":"https://stock-news.laohu8.com/highlight/detail?id=2584295415","media":"价值事务所","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584295415?lang=zh_cn&edition=full","pubTime":"2025-11-18 20:59","pubTimestamp":1763470750,"startTime":"0","endTime":"0","summary":"11月13日，诺诚健华发布三季度财报业绩报告，全年盈亏平衡引起资本市场关注。市场重新评估诺诚健华价值时刻到了。奥布替尼前三季度收入同比上涨45.8%，突破10亿元，已超去年全年收入。一直以来，市场不断有观点认为诺诚健华是一家价值被低估的公司。在这一轮结构性行情中，诺诚健华的表现的确引人瞩目。2025年9月全面商业化，已在20多个省份开出处方。此外，有一个细节值得一提，诺诚健华拥有充足的现金流。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118232311a4aa9cf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118232311a4aa9cf1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","BK1574","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"https://cn.innocarepharma.com","stockEarnings":[{"period":"1week","weight":-0.031},{"period":"1month","weight":0.0184},{"period":"3month","weight":-0.1887},{"period":"6month","weight":0.219},{"period":"1year","weight":1.1465},{"period":"ytd","weight":1.3464}],"compareEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":0.0058},{"period":"3month","weight":0.0262},{"period":"6month","weight":0.0964},{"period":"1year","weight":0.3336},{"period":"ytd","weight":0.3004}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"诺诚健华医药有限公司是一家主要从事生物医药研发、生产和商业化的中国公司。该公司专注于肿瘤和自身免疫性疾病等存在巨大未满足临床需求的领域。该公司的主要产品管线包括奥布替尼、Tafasitamab、ICP-490、ICP-B02、ICP-248、ICP-B05、ICP-332、ICP-488、ICP-192、ICP-723、ICP-033和ICP-189等。其产品主要用于治疗血液瘤、实体瘤和自身免疫病。该公司还在开发用于治疗由B细胞或T细胞功能异常所导致的自身免疫性疾病的产品。该公司主要在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.115368},{"month":2,"riseRate":0.6,"avgChangeRate":0.148393},{"month":3,"riseRate":0,"avgChangeRate":-0.036551},{"month":4,"riseRate":0.666667,"avgChangeRate":0.116223},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.042592},{"month":6,"riseRate":0.833333,"avgChangeRate":0.12939},{"month":7,"riseRate":0.5,"avgChangeRate":0.039258},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.082108},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.024907},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.033299},{"month":11,"riseRate":0.833333,"avgChangeRate":0.100833},{"month":12,"riseRate":0.5,"avgChangeRate":0.010522}],"exchange":"SEHK","name":"诺诚健华","nameEN":"INNOCARE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺诚健华(09969)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺诚健华(09969)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺诚健华,09969,诺诚健华股票,诺诚健华股票老虎,诺诚健华股票老虎国际,诺诚健华行情,诺诚健华股票行情,诺诚健华股价,诺诚健华股市,诺诚健华股票价格,诺诚健华股票交易,诺诚健华股票购买,诺诚健华股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺诚健华(09969)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺诚健华(09969)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}